INVESTOR PRESENTATION JUNE 2020 X 4 P H A R M A C E U T I C A L S I N V E S T O R D E C K FORWARD LOOKING STATEMENTS The statements herein are subject to various risks and uncertainties. These risks and uncertainties include, without limitation, the risk that trials and studies may be delayed and may not have satisfactory outcomes; potential adverse effects arising from the testing or use of mavorixafor or other product candidates; the risk that costs required to develop mavorixafor or other product candida ...

EHA 2020 Poster Highlights June 12, 2020 Safe Harbor Statement 2 This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. The words "may," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "believe," "estimate," "predict," "project," "potential," "continue," "target" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain th ...

INVESTOR PRESENTATION JUNE 2020 X4 PHARMACEUTICALS INVESTOR DECK FORWARD LOOKING STATEMENTS The statements herein are subject to various risks and uncertainties. These risks and uncertainties include, without limitation, the risk that trials and studies may be delayed and may not have satisfactory outcomes; potential adverse effects arising from the testing or use of mavorixafor or other product candidates; the risk that costs required to develop mavorixafor or other product candidates or to expand our oper ...

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q1 2020 Earnings Conference Call May 7, 2020 8:30 AM ET Company Participants Candice Ellis - Director of Corporate Communications & Investor Relations Paula Ragan - Chief Executive Officer Adam Mostafa - Chief Financial Officer Conference Call Participants Stephen Willey - Stifel Joel Beatty - Citi Swayampakula Ramakanth - H.C. Wainwright Laura Christianson - Cowen Trevor Allred - Oppenheimer Sahil Kazmi - B. Riley FBR Arlinda Lee - Canaccord Operator Greetings, and we ...

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q4 2019 Results Conference Call March 12, 2020 8:30 AM ET Company Participants Candice Ellis - IR Paula Ragan - CEO Lynne Kelley - CMO Adam Mostafa - CFO Conference Call Participants Stephen Willey - Stifel Arlinda Lee - Canaccord Genuity Marc Frahm - Cowen Joel Beatty - Citi Swayampakula Ramakanth - H.C. Wainwright Alex Heller - Oppenheimer Zegbeh Jallah - ROTH Capital Partners Operator Greetings and welcome to X4 Pharmaceuticals Fourth Quarter and Full Year 2019 Busi ...

INVESTOR PRESENTATION MARCH 2020 X 4 P H A R M A C E U T I C A L S I N V E S T O R D E C K FORWARD LOOKING STATEMENTS This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. The words "may," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "believe," "estimate," "predict," "project," "potential," "continue," "target" and similar expressions are intended to identify forward-looking statements, a ...